ROS1 rearrangements have been found in 1% to 2% of patients with NSCLC and were associated with younger-age, never smokers, Asian ethnicity, and, advanced stage (Gainor & Shaw, 2013; Bergethon et al., 2012). Here, ROS1 is linked to non-small cell lung carcinoma.